Impact and risk factors associated with Influenza H1N1 in Australian Hospital system, Epidemic 2009 (INFINITE 2009)
Principal Investigator: Dr Con Giannellis
INFINITE aims to establish a registry of patients admitted to ICU’s with Influenza A infection including swine flu. Investigators will establish reporting lines to allow for real-time provision of information to public health officials across Australia. This research is central to acquiring an early understanding of a global pandemic of major public health significance. An initial paper from this study was published in the prestigious New England Journal of Medicine last year.
Cyrstalloid versus Hydroxyethyl Starch Trial (CHEST) – A multi-centre randomised controlled trial of fluid resuscitation with starch (6% hydroxyethyl starch 130/0.4) compared to saline (0.9% sodium chloride) in intensive care patients on mortality
Principal Investigator: Dr Benno Ihle
Patients in ICU often require fluid to increase their blood pressure to acceptable levels or because the doctors treating them feel that the volume of fluid in the blood is inadequate. The main aim of this project is to find out whether critically ill adults with low blood volume who receive fluid resuscitation with Voluven® (a starch solution) compared to saline (a salt solution) have varying survival 90 days later.
Status: Recruiting
Contact: Clinical Trials and Research Centre